Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T-cell therapy of leukemia.

Stanley R Riddell1, Makoto Murata, Sophia Bryant

  • 1Immunology Program, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA. sriddell@fhcrc.org

Cancer Control : Journal of the Moffitt Cancer Center
|April 20, 2002
PubMed
Summary

Immune-based therapies show promise for leukemia treatment. Research is identifying new targets for T-cell therapy and vaccination to enhance anti-leukemic effects, potentially improving outcomes for transplant and non-transplant patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Haematologica·2026
Same author

Prognostic value of cardiopulmonary exercise testing parameters in young heart failure patients with moderately reduced exercise capacity.

JHLT open·2026
Same author

Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination.

Nature communications·2026
Same author

Transduction of Batf family members provides distinct functions to mouse CD8+ T cells.

International immunology·2026
Same author

The role of HLA transcription in unrelated hematopoietic cell transplantation.

Blood advances·2026
Same author

[Successful treatment of post-transplant steroid-refractory idiopathic pneumonia syndrome with etanercept and mycophenolate mofetil].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2025

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Allogeneic hematopoietic stem cell transplantation (HSCT) success is linked to immune-mediated leukemia elimination.
  • This finding has spurred interest in immune-based therapies for leukemia.
  • These therapies aim to enhance anti-leukemic effects, with or without HSCT.

Purpose of the Study:

  • To review mechanisms of T-cell recognition of leukemia post-HSCT.
  • To identify candidate target antigens for leukemia immunotherapy.
  • To evaluate antigen expression on leukemic progenitors.

Main Methods:

  • Literature review of studies on T-cell recognition mechanisms.
  • Identification of potential target antigens for immunotherapy.
  • Evaluation of candidate antigen expression on leukemic cells.

Related Experiment Videos

Main Results:

  • Numerous potential targets for T-cell therapy and vaccination in human leukemia have been identified.
  • Novel immune-based therapies are entering the evaluation phase.
  • Preclinical studies show promising results for immunotherapy.

Conclusions:

  • Advances in immunology offer new avenues for T-cell therapy and vaccination against leukemia.
  • Addressing current obstacles is crucial for broad application of these approaches.
  • Immunotherapy is poised to become a valuable clinical tool for leukemia treatment.